Skip to main content Skip to main content
Go to homepage

Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia COG AAML1331

Tretinoin and Arsenic Trioxide in Patients With Untreated Acute PML


For complete information, please visit the study on

Study Status:
Study Sponsor:

Children's Oncology Group

Full IRB Study Title:
A Phase III Study for Patients With Newly Diagnosed Acute Promyelocytic Leukemia (APL) Using Arsenic Trioxide and All-trans Retinoic Acid
IRB Study ID:
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email

By using this site, you consent to our use of cookies. To learn more, read our privacy policy.